aluates Reports

$ 0.0

Automative

Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-33S19787

BUY CHAPTERS

Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-33S19787

Report

October 2025

Pages:165

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Artificial Intelligence in Biomedical Market Size

The global Artificial Intelligence in Biomedical market is projected to grow from US$ 197 million in 2024 to US$ 1215 million by 2031, at a CAGR of 30.1% (2025-2031), driven by critical product segments and diverse end‑use applications.

Artificial Intelligence in Biomedical Market

Artificial Intelligence (AI) in biomedical refers to the application of AI technologies, such as machine learning, natural language processing, and computer vision, in the fields of medicine and biology. It is used to analyze complex biomedical data, assist in diagnostics, develop personalized treatment plans, discover new drugs, and improve healthcare outcomes. AI enhances the accuracy, speed, and efficiency of medical and biological research and clinical practices.

From a downstream perspective, Diagnosing Diseases accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Artificial Intelligence in Biomedical leading manufacturers including AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation, Novartis AG, NVIDIA Corporation, etc., dominate supply; the top five capture approximately % of global revenue, with AstraZeneca leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Artificial Intelligence in Biomedical market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Artificial Intelligence in Biomedical Market Report

Report Metric	Details
Report Name	Artificial Intelligence in Biomedical Market
Accounted market size in 2024	US$ 197 million
Forecasted market size in 2031	US$ 1215 million
CAGR	30.1%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Hardware Software
Segment by Application	Diagnosing Diseases Developing Drugs Personalized Treatment Other
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation, Novartis AG, NVIDIA Corporation, Pfizer, Recursion Pharmaceuticals, XtalPi Inc, Aidoc, AliveCor, GE Healthcare, Imagen Technologies, Vuno Inc., IDx Technologies Inc., Siemens Healthcare GmbH, Neural Analytics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Artificial Intelligence in Biomedical study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Artificial Intelligence in Biomedical Market growing?

Ans: The Artificial Intelligence in Biomedical Market witnessing a CAGR of 30.1% during the forecast period 2025-2031.

What is the Artificial Intelligence in Biomedical Market size in 2031?

Ans: The Artificial Intelligence in Biomedical Market size in 2031 will be US$ 1215 million.

Who are the main players in the Artificial Intelligence in Biomedical Market report?

Ans: The main players in the Artificial Intelligence in Biomedical Market are AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation, Novartis AG, NVIDIA Corporation, Pfizer, Recursion Pharmaceuticals, XtalPi Inc, Aidoc, AliveCor, GE Healthcare, Imagen Technologies, Vuno Inc., IDx Technologies Inc., Siemens Healthcare GmbH, Neural Analytics

What are the Application segmentation covered in the Artificial Intelligence in Biomedical Market report?

Ans: The Applications covered in the Artificial Intelligence in Biomedical Market report are Diagnosing Diseases, Developing Drugs, Personalized Treatment, Other

What are the Type segmentation covered in the Artificial Intelligence in Biomedical Market report?

Ans: The Types covered in the Artificial Intelligence in Biomedical Market report are Hardware, Software

1 Study Coverage

1.1 Introduction to Artificial Intelligence in Biomedical: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Artificial Intelligence in Biomedical Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Hardware

1.2.3 Software

1.3 Market Segmentation by Application

1.3.1 Global Artificial Intelligence in Biomedical Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Diagnosing Diseases

1.3.3 Developing Drugs

1.3.4 Personalized Treatment

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Artificial Intelligence in Biomedical Revenue Estimates and Forecasts 2020-2031

2.2 Global Artificial Intelligence in Biomedical Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Artificial Intelligence in Biomedical Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Artificial Intelligence in Biomedical Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Hardware Market Size by Players

3.3.2 Software Market Size by Players

3.4 Global Artificial Intelligence in Biomedical Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Artificial Intelligence in Biomedical Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Artificial Intelligence in Biomedical Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Artificial Intelligence in Biomedical Market Size by Type (2020-2031)

6.4 North America Artificial Intelligence in Biomedical Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Artificial Intelligence in Biomedical Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Artificial Intelligence in Biomedical Market Size by Type (2020-2031)

7.4 Europe Artificial Intelligence in Biomedical Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Artificial Intelligence in Biomedical Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Type (2020-2031)

8.4 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Artificial Intelligence in Biomedical Market Size by Type (2020-2031)

9.4 Central and South America Artificial Intelligence in Biomedical Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Artificial Intelligence in Biomedical Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Artificial Intelligence in Biomedical Market Size by Type (2020-2031)

10.4 Middle East and Africa Artificial Intelligence in Biomedical Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Artificial Intelligence in Biomedical Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 AstraZeneca

11.1.1 AstraZeneca Corporation Information

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Artificial Intelligence in Biomedical Product Features and Attributes

11.1.4 AstraZeneca Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.1.5 AstraZeneca Artificial Intelligence in Biomedical Revenue by Product in 2024

11.1.6 AstraZeneca Artificial Intelligence in Biomedical Revenue by Application in 2024

11.1.7 AstraZeneca Artificial Intelligence in Biomedical Revenue by Geographic Area in 2024

11.1.8 AstraZeneca Artificial Intelligence in Biomedical SWOT Analysis

11.1.9 AstraZeneca Recent Developments

11.2 Thales Group

11.2.1 Thales Group Corporation Information

11.2.2 Thales Group Business Overview

11.2.3 Thales Group Artificial Intelligence in Biomedical Product Features and Attributes

11.2.4 Thales Group Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.2.5 Thales Group Artificial Intelligence in Biomedical Revenue by Product in 2024

11.2.6 Thales Group Artificial Intelligence in Biomedical Revenue by Application in 2024

11.2.7 Thales Group Artificial Intelligence in Biomedical Revenue by Geographic Area in 2024

11.2.8 Thales Group Artificial Intelligence in Biomedical SWOT Analysis

11.2.9 Thales Group Recent Developments

11.3 IBM Corp.

11.3.1 IBM Corp. Corporation Information

11.3.2 IBM Corp. Business Overview

11.3.3 IBM Corp. Artificial Intelligence in Biomedical Product Features and Attributes

11.3.4 IBM Corp. Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.3.5 IBM Corp. Artificial Intelligence in Biomedical Revenue by Product in 2024

11.3.6 IBM Corp. Artificial Intelligence in Biomedical Revenue by Application in 2024

11.3.7 IBM Corp. Artificial Intelligence in Biomedical Revenue by Geographic Area in 2024

11.3.8 IBM Corp. Artificial Intelligence in Biomedical SWOT Analysis

11.3.9 IBM Corp. Recent Developments

11.4 ForeSee Medical

11.4.1 ForeSee Medical Corporation Information

11.4.2 ForeSee Medical Business Overview

11.4.3 ForeSee Medical Artificial Intelligence in Biomedical Product Features and Attributes

11.4.4 ForeSee Medical Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.4.5 ForeSee Medical Artificial Intelligence in Biomedical Revenue by Product in 2024

11.4.6 ForeSee Medical Artificial Intelligence in Biomedical Revenue by Application in 2024

11.4.7 ForeSee Medical Artificial Intelligence in Biomedical Revenue by Geographic Area in 2024

11.4.8 ForeSee Medical Artificial Intelligence in Biomedical SWOT Analysis

11.4.9 ForeSee Medical Recent Developments

11.5 Atomwise

11.5.1 Atomwise Corporation Information

11.5.2 Atomwise Business Overview

11.5.3 Atomwise Artificial Intelligence in Biomedical Product Features and Attributes

11.5.4 Atomwise Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.5.5 Atomwise Artificial Intelligence in Biomedical Revenue by Product in 2024

11.5.6 Atomwise Artificial Intelligence in Biomedical Revenue by Application in 2024

11.5.7 Atomwise Artificial Intelligence in Biomedical Revenue by Geographic Area in 2024

11.5.8 Atomwise Artificial Intelligence in Biomedical SWOT Analysis

11.5.9 Atomwise Recent Developments

11.6 Cloud Pharmaceuticals

11.6.1 Cloud Pharmaceuticals Corporation Information

11.6.2 Cloud Pharmaceuticals Business Overview

11.6.3 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product Features and Attributes

11.6.4 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.6.5 Cloud Pharmaceuticals Recent Developments

11.7 GNS Healthcare

11.7.1 GNS Healthcare Corporation Information

11.7.2 GNS Healthcare Business Overview

11.7.3 GNS Healthcare Artificial Intelligence in Biomedical Product Features and Attributes

11.7.4 GNS Healthcare Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.7.5 GNS Healthcare Recent Developments

11.8 Microsoft Corporation

11.8.1 Microsoft Corporation Corporation Information

11.8.2 Microsoft Corporation Business Overview

11.8.3 Microsoft Corporation Artificial Intelligence in Biomedical Product Features and Attributes

11.8.4 Microsoft Corporation Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.8.5 Microsoft Corporation Recent Developments

11.9 Novartis AG

11.9.1 Novartis AG Corporation Information

11.9.2 Novartis AG Business Overview

11.9.3 Novartis AG Artificial Intelligence in Biomedical Product Features and Attributes

11.9.4 Novartis AG Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.9.5 Novartis AG Recent Developments

11.10 NVIDIA Corporation

11.10.1 NVIDIA Corporation Corporation Information

11.10.2 NVIDIA Corporation Business Overview

11.10.3 NVIDIA Corporation Artificial Intelligence in Biomedical Product Features and Attributes

11.10.4 NVIDIA Corporation Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 Pfizer

11.11.1 Pfizer Corporation Information

11.11.2 Pfizer Business Overview

11.11.3 Pfizer Artificial Intelligence in Biomedical Product Features and Attributes

11.11.4 Pfizer Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.11.5 Pfizer Recent Developments

11.12 Recursion Pharmaceuticals

11.12.1 Recursion Pharmaceuticals Corporation Information

11.12.2 Recursion Pharmaceuticals Business Overview

11.12.3 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product Features and Attributes

11.12.4 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.12.5 Recursion Pharmaceuticals Recent Developments

11.13 XtalPi Inc

11.13.1 XtalPi Inc Corporation Information

11.13.2 XtalPi Inc Business Overview

11.13.3 XtalPi Inc Artificial Intelligence in Biomedical Product Features and Attributes

11.13.4 XtalPi Inc Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.13.5 XtalPi Inc Recent Developments

11.14 Aidoc

11.14.1 Aidoc Corporation Information

11.14.2 Aidoc Business Overview

11.14.3 Aidoc Artificial Intelligence in Biomedical Product Features and Attributes

11.14.4 Aidoc Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.14.5 Aidoc Recent Developments

11.15 AliveCor

11.15.1 AliveCor Corporation Information

11.15.2 AliveCor Business Overview

11.15.3 AliveCor Artificial Intelligence in Biomedical Product Features and Attributes

11.15.4 AliveCor Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.15.5 AliveCor Recent Developments

11.16 GE Healthcare

11.16.1 GE Healthcare Corporation Information

11.16.2 GE Healthcare Business Overview

11.16.3 GE Healthcare Artificial Intelligence in Biomedical Product Features and Attributes

11.16.4 GE Healthcare Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.16.5 GE Healthcare Recent Developments

11.17 Imagen Technologies

11.17.1 Imagen Technologies Corporation Information

11.17.2 Imagen Technologies Business Overview

11.17.3 Imagen Technologies Artificial Intelligence in Biomedical Product Features and Attributes

11.17.4 Imagen Technologies Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.17.5 Imagen Technologies Recent Developments

11.18 Vuno Inc.

11.18.1 Vuno Inc. Corporation Information

11.18.2 Vuno Inc. Business Overview

11.18.3 Vuno Inc. Artificial Intelligence in Biomedical Product Features and Attributes

11.18.4 Vuno Inc. Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.18.5 Vuno Inc. Recent Developments

11.19 IDx Technologies Inc.

11.19.1 IDx Technologies Inc. Corporation Information

11.19.2 IDx Technologies Inc. Business Overview

11.19.3 IDx Technologies Inc. Artificial Intelligence in Biomedical Product Features and Attributes

11.19.4 IDx Technologies Inc. Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.19.5 IDx Technologies Inc. Recent Developments

11.20 Siemens Healthcare GmbH

11.20.1 Siemens Healthcare GmbH Corporation Information

11.20.2 Siemens Healthcare GmbH Business Overview

11.20.3 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product Features and Attributes

11.20.4 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.20.5 Siemens Healthcare GmbH Recent Developments

11.21 Neural Analytics

11.21.1 Neural Analytics Corporation Information

11.21.2 Neural Analytics Business Overview

11.21.3 Neural Analytics Artificial Intelligence in Biomedical Product Features and Attributes

11.21.4 Neural Analytics Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)

11.21.5 Neural Analytics Recent Developments

12 Artificial Intelligence in BiomedicalIndustry Chain Analysis

12.1 Artificial Intelligence in Biomedical Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Artificial Intelligence in Biomedical Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Artificial Intelligence in Biomedical Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

List of Tables

Table 1. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Artificial Intelligence in Biomedical Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Artificial Intelligence in Biomedical Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Artificial Intelligence in Biomedical Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Artificial Intelligence in Biomedical Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Artificial Intelligence in Biomedical by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Biomedical as of 2024)

Table 11. Global Artificial Intelligence in Biomedical Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Artificial Intelligence in Biomedical Companies Headquarters

Table 13. Global Artificial Intelligence in Biomedical Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Artificial Intelligence in Biomedical Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Artificial Intelligence in Biomedical Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Artificial Intelligence in Biomedical Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Artificial Intelligence in Biomedical Revenue by Application (2026-2031) & (US$ Million)

Table 21. Artificial Intelligence in Biomedical High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Artificial Intelligence in Biomedical Growth Accelerators and Market Barriers

Table 25. North America Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Artificial Intelligence in Biomedical Growth Accelerators and Market Barriers

Table 27. Europe Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Artificial Intelligence in Biomedical Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Artificial Intelligence in Biomedical Investment Opportunities and Key Challenges

Table 31. Central and South America Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Artificial Intelligence in Biomedical Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. AstraZeneca Corporation Information

Table 35. AstraZeneca Description and Major Businesses

Table 36. AstraZeneca Product Features and Attributes

Table 37. AstraZeneca Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. AstraZeneca Revenue Proportion by Product in 2024

Table 39. AstraZeneca Revenue Proportion by Application in 2024

Table 40. AstraZeneca Revenue Proportion by Geographic Area in 2024

Table 41. AstraZeneca Artificial Intelligence in Biomedical SWOT Analysis

Table 42. AstraZeneca Recent Developments

Table 43. Thales Group Corporation Information

Table 44. Thales Group Description and Major Businesses

Table 45. Thales Group Product Features and Attributes

Table 46. Thales Group Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Thales Group Revenue Proportion by Product in 2024

Table 48. Thales Group Revenue Proportion by Application in 2024

Table 49. Thales Group Revenue Proportion by Geographic Area in 2024

Table 50. Thales Group Artificial Intelligence in Biomedical SWOT Analysis

Table 51. Thales Group Recent Developments

Table 52. IBM Corp. Corporation Information

Table 53. IBM Corp. Description and Major Businesses

Table 54. IBM Corp. Product Features and Attributes

Table 55. IBM Corp. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. IBM Corp. Revenue Proportion by Product in 2024

Table 57. IBM Corp. Revenue Proportion by Application in 2024

Table 58. IBM Corp. Revenue Proportion by Geographic Area in 2024

Table 59. IBM Corp. Artificial Intelligence in Biomedical SWOT Analysis

Table 60. IBM Corp. Recent Developments

Table 61. ForeSee Medical Corporation Information

Table 62. ForeSee Medical Description and Major Businesses

Table 63. ForeSee Medical Product Features and Attributes

Table 64. ForeSee Medical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. ForeSee Medical Revenue Proportion by Product in 2024

Table 66. ForeSee Medical Revenue Proportion by Application in 2024

Table 67. ForeSee Medical Revenue Proportion by Geographic Area in 2024

Table 68. ForeSee Medical Artificial Intelligence in Biomedical SWOT Analysis

Table 69. ForeSee Medical Recent Developments

Table 70. Atomwise Corporation Information

Table 71. Atomwise Description and Major Businesses

Table 72. Atomwise Product Features and Attributes

Table 73. Atomwise Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. Atomwise Revenue Proportion by Product in 2024

Table 75. Atomwise Revenue Proportion by Application in 2024

Table 76. Atomwise Revenue Proportion by Geographic Area in 2024

Table 77. Atomwise Artificial Intelligence in Biomedical SWOT Analysis

Table 78. Atomwise Recent Developments

Table 79. Cloud Pharmaceuticals Corporation Information

Table 80. Cloud Pharmaceuticals Description and Major Businesses

Table 81. Cloud Pharmaceuticals Product Features and Attributes

Table 82. Cloud Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Cloud Pharmaceuticals Recent Developments

Table 84. GNS Healthcare Corporation Information

Table 85. GNS Healthcare Description and Major Businesses

Table 86. GNS Healthcare Product Features and Attributes

Table 87. GNS Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. GNS Healthcare Recent Developments

Table 89. Microsoft Corporation Corporation Information

Table 90. Microsoft Corporation Description and Major Businesses

Table 91. Microsoft Corporation Product Features and Attributes

Table 92. Microsoft Corporation Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. Microsoft Corporation Recent Developments

Table 94. Novartis AG Corporation Information

Table 95. Novartis AG Description and Major Businesses

Table 96. Novartis AG Product Features and Attributes

Table 97. Novartis AG Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Novartis AG Recent Developments

Table 99. NVIDIA Corporation Corporation Information

Table 100. NVIDIA Corporation Description and Major Businesses

Table 101. NVIDIA Corporation Product Features and Attributes

Table 102. NVIDIA Corporation Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. NVIDIA Corporation Recent Developments

Table 104. Pfizer Corporation Information

Table 105. Pfizer Description and Major Businesses

Table 106. Pfizer Product Features and Attributes

Table 107. Pfizer Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. Pfizer Recent Developments

Table 109. Recursion Pharmaceuticals Corporation Information

Table 110. Recursion Pharmaceuticals Description and Major Businesses

Table 111. Recursion Pharmaceuticals Product Features and Attributes

Table 112. Recursion Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. Recursion Pharmaceuticals Recent Developments

Table 114. XtalPi Inc Corporation Information

Table 115. XtalPi Inc Description and Major Businesses

Table 116. XtalPi Inc Product Features and Attributes

Table 117. XtalPi Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. XtalPi Inc Recent Developments

Table 119. Aidoc Corporation Information

Table 120. Aidoc Description and Major Businesses

Table 121. Aidoc Product Features and Attributes

Table 122. Aidoc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 123. Aidoc Recent Developments

Table 124. AliveCor Corporation Information

Table 125. AliveCor Description and Major Businesses

Table 126. AliveCor Product Features and Attributes

Table 127. AliveCor Revenue (US$ Million) and Gross Margin (2020-2025)

Table 128. AliveCor Recent Developments

Table 129. GE Healthcare Corporation Information

Table 130. GE Healthcare Description and Major Businesses

Table 131. GE Healthcare Product Features and Attributes

Table 132. GE Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)

Table 133. GE Healthcare Recent Developments

Table 134. Imagen Technologies Corporation Information

Table 135. Imagen Technologies Description and Major Businesses

Table 136. Imagen Technologies Product Features and Attributes

Table 137. Imagen Technologies Revenue (US$ Million) and Gross Margin (2020-2025)

Table 138. Imagen Technologies Recent Developments

Table 139. Vuno Inc. Corporation Information

Table 140. Vuno Inc. Description and Major Businesses

Table 141. Vuno Inc. Product Features and Attributes

Table 142. Vuno Inc. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 143. Vuno Inc. Recent Developments

Table 144. IDx Technologies Inc. Corporation Information

Table 145. IDx Technologies Inc. Description and Major Businesses

Table 146. IDx Technologies Inc. Product Features and Attributes

Table 147. IDx Technologies Inc. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 148. IDx Technologies Inc. Recent Developments

Table 149. Siemens Healthcare GmbH Corporation Information

Table 150. Siemens Healthcare GmbH Description and Major Businesses

Table 151. Siemens Healthcare GmbH Product Features and Attributes

Table 152. Siemens Healthcare GmbH Revenue (US$ Million) and Gross Margin (2020-2025)

Table 153. Siemens Healthcare GmbH Recent Developments

Table 154. Neural Analytics Corporation Information

Table 155. Neural Analytics Description and Major Businesses

Table 156. Neural Analytics Product Features and Attributes

Table 157. Neural Analytics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 158. Neural Analytics Recent Developments

Table 159. Raw Materials Key Suppliers

Table 160. Distributors List

Table 161. Market Trends and Market Evolution

Table 162. Market Drivers and Opportunities

Table 163. Market Challenges, Risks, and Restraints

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. Artificial Intelligence in Biomedical Product Picture

Figure 2. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Hardware Product Picture

Figure 4. Software Product Picture

Figure 5. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Diagnosing Diseases

Figure 7. Developing Drugs

Figure 8. Personalized Treatment

Figure 9. Other

Figure 10. Artificial Intelligence in Biomedical Report Years Considered

Figure 11. Global Artificial Intelligence in Biomedical Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 13. Global Artificial Intelligence in Biomedical Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Artificial Intelligence in Biomedical Revenue Market Share by Region (2020-2031)

Figure 15. Global Artificial Intelligence in Biomedical Revenue Market Share Ranking (2024)

Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 17. Hardware Revenue Market Share by Player in 2024

Figure 18. Software Revenue Market Share by Player in 2024

Figure 19. Global Artificial Intelligence in Biomedical Revenue Market Share by Type (2020-2031)

Figure 20. Global Artificial Intelligence in Biomedical Revenue Market Share by Application (2020-2031)

Figure 21. North America Artificial Intelligence in Biomedical Revenue YoY (2020-2031) & (US$ Million)

Figure 22. North America Top 5 Players Artificial Intelligence in Biomedical Revenue (US$ Million) in 2024

Figure 23. North America Artificial Intelligence in Biomedical Revenue (US$ Million) by Type (2020 - 2031)

Figure 24. North America Artificial Intelligence in Biomedical Revenue (US$ Million) by Application (2020-2031)

Figure 25. US Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 26. Canada Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 27. Mexico Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 28. Europe Artificial Intelligence in Biomedical Revenue YoY (2020-2031) & (US$ Million)

Figure 29. Europe Top 5 Players Artificial Intelligence in Biomedical Revenue (US$ Million) in 2024

Figure 30. Europe Artificial Intelligence in Biomedical Revenue (US$ Million) by Type (2020-2031)

Figure 31. Europe Artificial Intelligence in Biomedical Revenue (US$ Million) by Application (2020-2031)

Figure 32. Germany Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 33. France Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 34. U.K. Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 35. Italy Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 36. Russia Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Artificial Intelligence in Biomedical Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Top 8 Players Artificial Intelligence in Biomedical Revenue (US$ Million) in 2024

Figure 39. Asia-Pacific Artificial Intelligence in Biomedical Revenue (US$ Million) by Type (2020-2031)

Figure 40. Asia-Pacific Artificial Intelligence in Biomedical Revenue (US$ Million) by Application (2020-2031)

Figure 41. Indonesia Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 42. Japan Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 43. South Korea Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 44. Australia Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 45. India Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 46. Indonesia Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 47. Vietnam Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 48. Malaysia Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 49. Philippines Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 50. Singapore Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)

Figure 51. Central and South America Artificial Intelligence in Biomedical Revenue YoY (2020-2031) & (US$ Million)

Figure 52. Central and South America Top 5 Players Artificial Intelligence in Biomedical Revenue (US$ Million) in 2024

Figure 53. Central and South America Artificial Intelligence in Biomedical Revenue (US$ Million) by Type (2020-2031)

Figure 54. Central and South America Artificial Intelligence in Biomedical Revenue (US$ Million) by Application (2020-2031)

Figure 55. Brazil Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)

Figure 56. Argentina Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)

Figure 57. Middle East and Africa Artificial Intelligence in Biomedical Revenue YoY (2020-2031) & (US$ Million)

Figure 58. Middle East and Africa Top 5 Players Artificial Intelligence in Biomedical Revenue (US$ Million) in 2024

Figure 59. South America Artificial Intelligence in Biomedical Revenue (US$ Million) by Type (2020-2031)

Figure 60. Middle East and Africa Artificial Intelligence in Biomedical Revenue (US$ Million) by Application (2020-2031)

Figure 61. GCC Countries Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)

Figure 62. Israel Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)

Figure 63. Egypt Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)

Figure 64. South Africa Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)

Figure 65. Artificial Intelligence in Biomedical Industry Chain Mapping

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-33S19787

Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Artificial Intelligence in Biomedical Market Size

Artificial Intelligence in Biomedical Market

Report Includes:

Scope of Artificial Intelligence in Biomedical Market Report

Chapter Outline

FAQ for this report

How fast is Artificial Intelligence in Biomedical Market growing?

What is the Artificial Intelligence in Biomedical Market size in 2031?

Who are the main players in the Artificial Intelligence in Biomedical Market report?

What are the Application segmentation covered in the Artificial Intelligence in Biomedical Market report?

What are the Type segmentation covered in the Artificial Intelligence in Biomedical Market report?

FEATURED COMPANIES